Erisyon Inc.
NY
- UEI
- XBCYESFSZJM6
- CAGE
- 850X3
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 165 Luquer St #1, Brooklyn, NY 11231, USA
- Website
- erisyon.com
- Founded
- 2018
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Electronic Biosciences, Inc. | San Diego, CA | 541330 Engineering Services |
| Pumpkinseed Technologies Inc. | Palo Alto, CA | 541713 Research and Development in Nanotechnology |
| Proteinaceous Inc. | Evanston, IL | 541690 Other Scientific and Technical Consulting Services |
| Protein Metrics, LLC | Boston, MA | 513210 Software Publishers |
| GMJ Technologies, Inc. | Everett, WA | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
About the company
Erisyon Inc. is a company that is transforming the field of proteomics with the world's first single molecule protein sequencer. With unparalleled sensitivity and scalability, Erisyon enables new applications across the Life Sciences. The company is registered as a for-profit corporate entity to receive awards from the U.S. federal government.
Erisyon Inc. has received several federal grant awards from agencies such as the National Institutes of Health (NIH) and the National Science Foundation (NSF) for projects related to single molecule protein sequencing and analysis. One notable project, funded by the NIH's National Human Genome Research Institute, involved "STRUCTURAL PROFILING OF NATIVE PROTEINS USING FLUOROSEQUENCING, A SINGLE MOLECULE PROTEIN SEQUENCING TECHNOLOGY" to better understand the impact of genomic mutations on protein structure and function. Another project, funded by the NIH's National Institute of Neurological Disorders and Stroke, focused on "SINGLE MOLECULE PROTEIN SEQUENCING OF ALPHA-SYNUCLEIN SPECIES FOR PARKINSON'S DISEASE DIAGNOSTICS." Additionally, the NSF awarded Erisyon Inc. a grant for "SINGLE MOLECULE SEQUENCING OF PHOSPHORYLATED PROTEINS FOR NEXT-GENERATION PROTEIN ANALYSES AND DIAGNOSTICS." These projects demonstrate Erisyon Inc.'s expertise in developing and applying advanced protein sequencing technologies for various life science applications, including disease diagnostics and understanding the relationship between genomic variations and protein structure/function.
Quick answers
Is Erisyon Inc. registered in SAM.gov?
Yes. Erisyon Inc.'s SAM.gov registration is active through October 1, 2027.
What is Erisyon Inc.'s most recent federal award?
Erisyon Inc.'s most recent federal grant award is Structural profiling of native proteins using fluorosequencing, a single molecule protein sequencing technology (R43HG012561), from National Human Genome Research Institute (NIH), on September 22, 2022.
On GovTribe
See Erisyon Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors